Tango Therapeutics, Inc. (TNGX)
NGM – Real Time Price. Currency in USD
26.31
-0.03 (-0.11%)
Market open: Aug 12, 2026, 12:43 PM EDT
26.23
-0.11 (-0.42%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
26.31
-0.03 (-0.11%)
Market open: Aug 12, 2026, 12:43 PM EDT
26.23
-0.11 (-0.42%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
| Name | Position |
|---|---|
| Dr. Adam S. Crystal M.D., Ph.D. | President of Research & Development |
| Dr. Janice Kapty Ph.D. | Senior Vice President of Corporate Strategy & Project Leadership |
| Dr. Philippe Serrano | Chief Regulatory Officer |
| Mr. Jannik N. Andersen Ph.D. | Chief Scientific Officer |
| Mr. Matthew Gall M.B.A. | Chief Financial Officer |
| Ms. Daniella Beckman CPA | Executive Officer |
| Ms. Elizabeth Pingpank Hickin | VP of IR & Corporate Communications |
| Ms. Julie Carretero | Chief Human Resources Officer |
| Ms. Julie Fogarty | Senior VP, General Counsel & Corporate Secretary |
| Ms. Yen-Ching Chua | Chief Development Operations Office |
| Date | Type | Document |
|---|---|---|
| 2026-08-11 | 10-Q | tngx-20260630.htm |
| 2026-08-07 | 8-K/A | d215768d8ka.htm |
| 2026-08-06 | 8-K | d41277d8k.htm |
| 2026-06-23 | 8-K | d79260d8k.htm |
| 2026-06-10 | 8-K | d81492d8k.htm |
| 2026-06-08 | 8-K | d158334d8k.htm |
| 2026-06-04 | 8-K | d149262d8k.htm |
| 2026-05-13 | 8-K | tngx-20260513.htm |
| 2026-05-13 | 10-Q | tngx-20260331.htm |
| 2026-05-08 | 8-K | d102174d8k.htm |